Mr Mrs Miss Ms Dr Other

Dr
Aron
Ferenczi

Trainee Patent Attorney

Glasgow Office Edinburgh Office

Life sciences

Telephone. +44(0) 141 229 5800
Email. aferenczi@hgf.com

Experience

Aron holds a PhD in molecular and cellular biology and works on a diverse range of largely nucleotide, peptide and cell-based technologies. He has in-depth knowledge of plants and algae, gene editing and DNA repair, with a professional interest in these areas as well as food and drink technologies. He is involved in the Food Technology, Agritech and Gene Editing sector specialisms within the Life Sciences group.

His patent practice draws on six years of research experience, during which he developed a novel gene-editing technique and studied the DNA repair pathways involved in the model green alga Chlamydomonas reinhardtii. He is also experienced in plant-based transient gene expression. His research findings have been published in high-impact journals including Nature Communications and PNAS. During and after his PhD, he worked at a startup specialising in the microalgae-based food industry.

Aron graduated from The University of Edinburgh with an honours degree in Biological Sciences specialising in Plant Science. He completed an undergraduate internship in wheat genetics at the John Innes Centre. He has a Master’s degree in Bioinformatics and a PhD from the same university. He joined HGF in 2023.

Qualifications

Trainee


BSC

(Hons) Biological Sciences (Plant Science)

MSC

Bioinformatics

PHD

Cell and Molecular Biology

Publications

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

View publication online

The Bite of Implied Consent: Lessons from the Pink Lady Case

View publication online

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

View publication online

IP Ingredients: Can you patent a flavour?

View publication online

Can you patent a flavour?

View publication online

Comparison of CRISPR/Cas9 and Cas12a for gene editing in Chlamydomonas reinhardtii

View publication online

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Zombie Fashion Brands

Episode 4 Zombie Fashion Brands  

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.